PATENT CLAIM ANALYSIS

Application Number: 16305021
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "108000"]

Abstract:
The present invention is in the field of a use of a bisphophosphonate acid, specifically a salt thereof, or analogue thereof, or combinations thereof, in a medicament for naturally occurring diseases/disorders in a mammal, the mammal being selected from the orders of Perissodactyla, such as the family of Equidae (horses), (Cet) Artiodactyla, such as the family of Bovidae (cattle), and Carnivora, such as the families of Canidae (e.g. dogs) and Felidae (e.g. cats).

Claim (Index 13):
The medicament compound according to  claim 10 , wherein the bisphosphonate is selected from Pamidronate ( FIG. 1 c ), Nerodronate ( FIG. 1 d ), Olpadronate ( FIG. 1 e ), amino-hydroxy-(n-hydroxy-oxido-phosphoryl)-alkyl-phosphonic acid according to  FIG. 1 b , Alendronate ( FIG. 1 i ), Ibandronate ( FIG. 1 f ), Risedronate ( FIG. 1 g ), and Zoledronate ( FIG. 1 h ).

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 1.92
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10470924', '12191264', '11911679', '11867919', '14175254']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7172616934553265
- 35 USC 102 Novelty (BERT): 0.4786819483395907
- Combined Prediction Score: 0.693403718943753
- Mean Citation Score: 177.00638400000005
- Max Citation Score: 189.10039
- Similarity Product: 155.36210019150138

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test